Stable
aqueous dispersions of citrate-stabilized gold nanorods
(cit-GNRs) have been prepared in scalable fashion by surfactant exchange
from cetyltrimethylammonium bromide (CTAB)-stabilized GNRs, using
polystyrenesulfonate (PSS) as a detergent. The surfactant exchange
process was monitored by infrared spectroscopy, surface-enhanced Raman
scattering (SERS), and X-ray photoelectron spectroscopy (XPS). The
latter established the quantitative
displacement of CTAB (by PSS) and of PSS (by citrate). The Cit-GNRs
are indefinitely stable at low ionic strength, and are conducive to
further ligand exchange without loss of dispersion stability. The
reliability of the surface exchange process supports the systematic
analysis of ligand structure on the hydrodynamic size of GNRs, as
described in a companion paper.
Nanomedicine-based approaches to cancer treatment face several challenges that differ from those encountered by conventional medicines during clinical development. A systematic exploration of these issues has led us to identify the following needs and opportunities for further development: (1) robust and general methods for the accurate characterization of nanoparticle size, shape, and composition; (2) scalable approaches for producing nanomedicines with optimized bioavailability and excretion profiles; (3) particle engineering for maintaining low levels of nonspecific cytotoxicity and sufficient stability during storage; (4) optimization of surface chemistries for maximum targeted delivery and minimum nonspecific adsorption; (5) practical methods for quantifying ligand density and distributions on multivalent nanocarriers; and (6) the design of multifunctional nanomedicines for novel combination therapies with supportable levels of bioaccumulation.
Polyethylene glycol (PEG) derivatives were conjugated onto the Cys-34 residue of human serum albumin (HSA) to determine their effects on the solubilization, permeation, and cytotoxic activity of hydrophobic drugs such as paclitaxel (PTX). PEG(C34)HSA conjugates were prepared on a multigram scale by treating native HSA (n-HSA) with 5- or 20-kDa mPEG-maleimide, resulting in up to 77% conversion of the mono-PEGylated adduct. Nanoparticle tracking analysis of PEG(C34)HSA formulations in phosphate buffer revealed an increase in nanosized aggregates relative to n-HSA, both in the absence and presence of PTX. Cell viability studies conducted with MCF-7 breast cancer cells indicated that PTX cytotoxicity was enhanced by PEG(C34)HSA when mixed at 10:1 mole ratios, up to a two-fold increase in potency relative to n-HSA. The PEG(C34)HSA conjugates were also evaluated as PTX carriers across monolayers of HUVEC and hCMEC/D3 cells, and found to have nearly identical permeation profiles as n-HSA.
The
stability and hydrodynamic size of ligand-coated gold nanorods
(GNRs; aspect ratio 3.6) have been characterized by nanoparticle tracking
analysis (NTA)—a single-particle counting method that can measure
size distributions with low nanometer resolution. Stable aqueous suspensions
of citrate-stabilized GNRs (cit-GNRs) are amenable to surface functionalization
without loss of dispersion control. Cit-GNRs can be treated with chemisorptive
ligands (thiols and dithiocarbamates), nonionic surfactants (Tween
20), and proteins (human serum albumin), all of which produce stable
suspensions at low surfactant concentrations. The precision of NTA
(relative standard deviation 10–12%, standard error <2%)
is sufficient to allow differences in the hydrodynamic size of coated
GNRs to be interpreted in terms of surfactant structure and conformation.
Aim
The synergistic effects of gold nanorod (GNR)-mediated mild hyperthermia (MHT; 42–43°C) and cisplatin (CP) activity was evaluated against chemoresistant SKOV3 cells in vitro and with a tumor xenograft model.
Materials & methods
In vitro studies were performed using CP at cytostatic concentrations (5 μM) and polyethylene glycol-stabilized GNRs, using near-infrared laser excitation for MHT.
Results
The amount of polyethylene glycol-GNRs used for environmental MHT was 1 μg/ml, several times lower than the loadings used in tumor tissue ablation. GNR-mediated MHT increased CP-mediated cytotoxicity by 80%, relative to the projected additive effect, and flow cytometry analysis suggested MHT also enhanced CP-induced apoptosis. In a pilot in vivo study, systemically administered polyethylene glycol-GNRs generated sufficient levels of MHT to enhance CP-induced reductions in tumor volume, despite their heterogeneous distribution in tumor tissue.
Conclusion
These studies imply that effective chemotherapies can be developed in combination with low loadings of nanoparticles for localized MHT.
Pdx1 exon2 (Figure 4) through pancreatic duct infusion into the pancreas.RESULTS AND CONCLUSIONS: These CRISPR-SaCas9 and gRNAs AAV viruses were co-infused into pancreases of C57BL/6J mice 2 days after alloxan treatment. One week after AAV6-SaCas9+gRNAs infusion, it appeared that only the Pdx1 in pancreatic ductal cells were deleted. Comparatively, PBS or AAV6-CMV-GFP viral infused C57BL/6J mice and ROSA26 LSL tomato reporter mice expressed fl uorescence in the entire pancreas as a result of the deleted loxP sites that removed the stop cassette, the Pdx1 is not deleted. Thus, we fi rst report here a highly effi cient and specifi c ablation of Pdx1 in adult mouse pancreatic ducts using the CRISPR-Cas9 technique.Figure 1.Construction of AAV CRISPR-SaCas9 and gRNA vectors. Figure 2. Deletion of ZsGeen in HEK293-CMV-GFP cells using SacCas9 and gRNA in vitro. Figure 3. Valiation of SaCas9 and gRNA in vivo deletion of loxP sites in ROSA26-LSL tomato mice pancreas. Figure 4. Deletion of Pdx1 exon2 in alloxan treated C57 pancreatic ducts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.